How to Choose Membrane Proteins for Therapeutic Antibody Screening

Choosing the right membrane-protein format can improve epitope presentation, assay compatibility, and antibody-screening efficiency. Beta LifeScience offers full-length transmembrane proteins in VLP, nanodisc, and detergent-solubilized formats for immunization, ELISA, SPR, BLI, and other research workflows. Researchers can compare available catalog targets or submit a GPCR, ion channel, transporter or tumor-associated membrane protein for custom evaluation.

• Browse Transmembrane Proteins
• Submit a Membrane Protein Project

Selection should not be based on the target name alone. Confirm the complete construct, membrane format, expression host, tag, orientation, validation method, purity, endotoxin level, and compatibility with the planned screening platform.

Membrane Protein Solutions from Beta LifeScience

Beta LifeScience offers an expanding catalog of recombinant transmembrane proteins across VLP, nanodisc and detergent-solubilized formats. Its catalog includes GPCRs, claudins, transporters, ion channels, tetraspanins and other tumor-associated membrane targets.

These formats are designed to support native-like membrane presentation, appropriate folding and application-relevant biological activity. Actual performance and validation differ by product, so researchers should review each product page before ordering.

Researchers can begin with a catalog product and move to custom production when the required target, species, mutation, tag, or membrane format is unavailable.

Why Membrane-Protein Format Matters

Therapeutic antibodies commonly recognize exposed extracellular epitopes. Their binding can depend on more than the target’s linear amino-acid sequence.

Relevant factors include:

• Protein conformation
• Membrane topology
• Extracellular-loop orientation
• Disulfide-bond formation
• Glycosylation
• Oligomeric state
• Surrounding lipids
• Association with partner proteins

A soluble extracellular domain may be sufficient when the complete therapeutic epitope is contained within an independently folded domain. However, it may not reproduce a conformational epitope formed by a full-length multi-pass protein within a membrane.

This distinction is particularly important for GPCRs, claudins, ion channels, transporters, and tetraspanins because their extracellular regions can be short or influenced by the surrounding lipid environment.

VLP vs Nanodisc vs Detergent Formats

Choose VLPs for Immunization and ELISA Screening

Virus-like particles display full-length membrane proteins within a lipid envelope. This format can present extracellular regions in a membrane-associated environment and provide repeated target display.

Beta LifeScience’s VLP transmembrane protein collection is primarily positioned for:

• Animal immunization
• Antibody generation
• ELISA antibody screening
• Epitope identification
• Binding validation
• Selected structural and functional studies

Available targets include GPCRs, claudins, CD20, CD133, STEAP1, GPRC5D, and other therapeutic research targets.

Beta LifeScience’s general VLP guidance does not position conventional VLP products for routine SPR, BLI or conventional flow-cytometry workflows. However, selected biotinylated VLP product pages may include product-specific analytical validation. Researchers should therefore follow the individual product datasheet.

Choose Nanodiscs for ELISA, SPR and BLI

Nanodiscs contain a phospholipid bilayer surrounded by membrane scaffold proteins. They provide a controlled and soluble membrane-mimetic environment for full-length multi-pass proteins.

Beta LifeScience’s nanodisc transmembrane proteins can be considered for:

• Therapeutic antibody screening
• ELISA binding studies
• SPR and BLI kinetic analysis
• Affinity measurement
• Epitope mapping
• Bispecific-antibody research
• ADC-binding research
• Selected structural and mechanism studies

Site-specific biotinylated nanodiscs can support directional capture on streptavidin-coated plates or biosensors. Confirm the location of the biotin label and whether the capture method could interfere with the antibody-binding epitope.

Choose Detergent-Solubilized Proteins for Biochemical Research

Detergents surround hydrophobic transmembrane regions and help keep purified membrane proteins soluble outside a lipid bilayer.

Detergent-solubilized proteins may support:

• Biochemical characterization
• Ligand-binding studies
• Protein engineering
• Small-molecule screening
• Purification development
• Selected structural workflows

The detergent type and concentration can influence protein stability, aggregation, and conformation. Buyers should therefore review product-specific biochemical or functional evidence instead of assuming that every detergent preparation is equally compatible with antibody screening.

Match the Format to the Antibody-Screening Stage

Immunization and antibody generation

For antibodies intended to recognize extracellular epitopes, consider a VLP or another full-length membrane-associated antigen. Review:

• Target density
• Extracellular epitope exposure
• Species sequence
• Glycosylation
• Endotoxin level
• Immunization compatibility

Primary antibody screening

VLP- or nanodisc-based ELISA can help identify antibody clones that bind the membrane-associated target. Include an appropriate empty VLP or nanodisc control to detect antibodies against the particle, lipid, scaffold, or other non-target components.

Affinity and kinetic characterization

Nanodiscs can support quantitative association and dissociation measurements by SPR or BLI when supported by the product specifications.

Confirm:

• Immobilization strategy
• Surface density
• Tag accessibility
• Reference subtraction
• Mass-transport conditions
• Product-specific validation

Cell-based confirmation

Recombinant proteins provide a controlled screening reagent, while cell-based assays can confirm binding to the target in a cellular membrane environment. Depending on the program, researchers may also evaluate competition, internalization, receptor modulation, or downstream functional responses.

Featured Membrane Proteins for Therapeutic Antibody Screening

These best-fit research applications are provided for initial product selection. Confirm the complete sequence, formulation, QC documentation, and assay compatibility on the individual product page before ordering.

Browse All Transmembrane Proteins

Request Pricing and Availability

Check the Construct and Therapeutic Epitope

Confirm whether the product contains a full-length protein or only an extracellular domain. For full-length products, review the sequence boundaries and relevant isoform.

Ask:

• Is the therapeutic epitope included?
• Is this the correct target isoform?
• Are all transmembrane helices present?
• Are any stabilizing mutations included?
• Is the N- or C-terminus modified?
• Does the target require a partner protein?
• Is the target epitope conformational?
• Could a tag interfere with antibody binding?

An antibody that binds a linear peptide may not recognize a membrane-associated conformational epitope. Similarly, an antibody selected using a membrane-associated target may not bind a denatured protein in Western blotting.

Evaluate the Expression Host

Many therapeutic antibody targets contain extracellular disulfide bonds or glycosylation sites. Mammalian expression can be considered when eukaryotic folding and post-translational processing matter.

Beta LifeScience lists HEK293 mammalian expression for its VLP and nanodisc product platforms. This system is designed to support membrane insertion and eukaryotic processing, although equivalence to the target in a particular tissue or disease state should not be assumed.

Confirm whether:

• Glycosylation could affect the epitope
• Human and preclinical-species orthologs are required
• The host could introduce background reactivity
• The antibody should recognize a specific disease-associated conformation
• Species cross-reactivity must be evaluated

Check Tags, Biotinylation and Immobilization

His, Flag, Fc, and biotin labels can simplify purification, immobilization, and detection. Their position can also influence target orientation or epitope accessibility.

For SPR or BLI, define the capture method before ordering:

• His-tag capture
• Biotin–streptavidin capture
• Antibody capture
• Amine coupling
• Product-specific capture chemistry

Site-specific biotinylation can provide more controlled capture than random chemical labelling. However, suitability still depends on the epitope, label position and membrane-protein format. Include empty nanodisc, empty VLP, irrelevant membrane-protein and tag-matched controls where appropriate.

Compare Product-Specific QC

Purity alone does not establish correct extracellular epitope presentation or assay suitability. Review QC data that relates directly to the intended screening workflow.

Useful documentation may include:

• SDS-PAGE or HPLC purity
• Protein concentration
• Particle-size or distribution analysis
• Endotoxin testing
• ELISA antibody-binding data
• SPR or BLI affinity data
• Ligand-binding results
• Biotinylation confirmation
• Lot-specific Certificate of Analysis
• Storage and freeze–thaw instructions

For example, Recombinant Human A2AR Nanodisc, BLK-03218P is listed as an HEK293-expressed full-length A2AR construct containing Met1–Ser412 with a C-terminal His tag. Its product page reports ELISA antibody binding and an SPR affinity measurement. These data apply to BLK-03218P and should not be generalized to every nanodisc protein.

Catalog or Custom Membrane Protein Production?

A catalog product is the most direct option when its target, species, isoform, construct, tag, and format match the screening workflow.

Custom development may be appropriate when the project requires:

• An unavailable GPCR, ion channel or transporter
• A different species or isoform
• A disease-associated mutation
• A specific extracellular-loop sequence
• Full-length instead of soluble-domain expression
• VLP, nanodisc or detergent-format conversion
• Site-specific biotinylation
• An alternative tag
• Application-specific QC
• Larger quantities

Beta LifeScience provides VLP membrane protein production, nanodisc membrane protein production and cell-free membrane protein expression for selected difficult targets.

Feasibility, deliverables, QC testing, quantity, lead time and pricing should be confirmed in the project quotation.

How to Start a Membrane Protein Project

1. Identify the target, species, isoform and accession number.
2. Define the therapeutic epitope or extracellular region.
3. Specify whether the project involves immunization, ELISA, SPR, BLI or functional testing.
4. Choose an initial VLP, nanodisc or detergent format.
5. Define the tag, biotinylation, and immobilization strategy.
6. Specify quantity, purity, endotoxin and QC requirements.
7. Search the transmembrane protein catalog.
8. Use the Online Inquiry form for catalog pricing and availability.
9. Submit an unavailable or modified target through the Project Evaluation form.

FAQs:

Which membrane-protein format is best for antibody screening?

VLPs are primarily positioned for immunization and ELISA screening. Nanodiscs provide broader compatibility with ELISA, SPR and BLI. Selection depends on the target, epitope, screening stage, and product-specific validation.

Are VLP membrane proteins suitable for SPR or BLI?

Beta LifeScience’s general VLP guidance does not recommend conventional VLP products for routine SPR or BLI. Selected biotinylated VLP products may have product-specific validation, so check the individual product page.

Why are nanodiscs useful for antibody screening?

Nanodiscs hold a membrane protein within a controlled phospholipid bilayer while keeping the complex soluble. This format can support membrane-associated epitope presentation and multiple binding-analysis workflows.

Should I choose a full-length protein or soluble domain?

Choose a soluble domain when it independently folds and contains the complete epitope. Consider a full-length membrane format when binding depends on membrane topology, extracellular loops, or a lipid-associated conformation.

Can Beta LifeScience produce a custom GPCR or transporter?

Beta LifeScience offers custom development for selected GPCRs, claudins, tetraspanins, ion channels, transporters and other complex targets. Feasibility and format are evaluated for each project.

How can I request a quotation?

Submit the target, sequence, species, desired format, tag, quantity, and intended assay through the Online Inquiry form or Project Evaluation form.

Request a Membrane Protein Quote

Include these details with your inquiry:

• Target name and species
• Full-length sequence or accession number
• Required VLP, nanodisc or detergent format
• Preferred tag or biotinylation
• Intended ELISA, SPR, BLI or immunization workflow
• Required quantity
• Purity, endotoxin and QC specifications

Providing these requirements helps Beta LifeScience evaluate a relevant format, catalog option, or custom production route.

• Browse Transmembrane Proteins
• Request Pricing and Availability
• Submit a Custom Membrane Protein Project

Beta LifeScience membrane-protein products are supplied for research use. Confirm product-specific specifications and intended use on the individual product page before ordering.